Director of IrsiCaixa AIDS Research Institute. President of the Fight Infections Foundation. Universitat de Vic.. Barcelona, Spain
Bonaventura Clotet specialized in Internal Medicine and Infectious Diseases and obtained his PhD in Medical Sciences. Director of the IrsiCaixa AIDS Research Institute. He is also President of the Fight AIDS Foundation. He is co-director of HIVACAT, the Catalan project for the development of an AIDS vaccine. Director of the Master in AIDS Pathogenesis and Treatment (Universitat Autònoma de Barcelona) from 2011 to 2016. Dr. Clotet is a member of the steering committee of the EuroSIDA Scientific Advisory Board and director of the Chair of AIDS and Related Diseases at the Universitat de Vic (UVic). He was awarded by the Catalan Government with the Josep Trueta medal to Sanitary Merit for his contributions to the research in the HIV field. He also received the Creu de Sant Jordi for being one of the most internationally renowned HIV researchers. Dr. Clotet has created 2 spin-offs from IrsiCaixa: AELIX Therapeutics, for the development of a HIV therapeutic vaccine, and AlbaJuna Therapeutics, for the development of immunoglobulins to cure and prevent HIV. He has published more than 700 papers in international journals (Impact factor: >5.000 // H-index: 81).